Feedback / Questions
SAT-3247 - Satellos Biosci
https://www.businesswire.com/news/home/20260212393921/en/Satellos-Announces-First-Participant-Dosed-in-Phase-2-Pediatric-Study-of-SAT-3247-for-Duchenne-Muscular-Dystrophy
Feb 12, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next